CAP6

The Argument for Systemic Thrombolytics in Submassive Pulmonary Embolism. Swami at St.Emlyn’s

Anand Swaminathan revisits his SMACCDub argument for considering thrombolysis in selected patients with submassive pulmonary embolism. This 2017 opinion piece weighs possible functional benefits against major bleeding, emphasising patient selection, shared decisions and the uncertainty in the evidence available then.

The Argument for Systemic Thrombolytics in Submassive Pulmonary Embolism. Swami at St.Emlyn’s Read More

Scroll to Top